Yahoo! Finance Search - Finance Home - Yahoo! - Help

Monday, March 30 2015 3:12am ET - U.S. Markets open in 6 hours and 18 minutes.
Industry Center - Drug Delivery
Industry Center > Drug Delivery > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Delivery News
Latest News
Friday, Mar 27, 2015
·13D Filings
at - Fri Mar 27
·Adamis Pharmaceuticals Receives Complete Response Letter From FDA for Its Epinephrine Pre-Filled Syringe NDA
GlobeNewswire - Fri Mar 27
·Alkermes 'Taking A Pause,' Citi Says
- Fri Mar 27
·Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares
CNW Group - Fri Mar 27
·Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares
PR Newswire - Fri Mar 27
·Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting
PR Newswire - Fri Mar 27
·Flamel Technologies Announces Positive Results of a First-in-Man Clinical Trial With LiquiTime(R) Guaifenesin
Marketwire - Fri Mar 27
Wednesday, Mar 25, 2015
·Ackman Boosts Stake In Valeant; Still Appears To Be Passive
- Wed Mar 25
Tuesday, Mar 24, 2015
·Salix had a $13B offer on the table before accounting problems crashed share price
at - Tue Mar 24
·Talking Allergan at Tulane: a 'Horse Choker,' the 'Shamarendum' and More
at The Wall Street Journal Online - Tue Mar 24
Monday, Mar 23, 2015
·Alkermes plc -- Moody's affirms Alkermes' Ba3 ratings; changes outlook to stable
- Mon Mar 23
·Alkermes to Present Data on Aripiprazole Lauroxil and ALKS 3831 at 15th International Congress on Schizophrenia Research
Business Wire - Mon Mar 23
·Acura Pharmaceuticals Reports Successful Topline Results From Nexafed(R) Extended-Release Clinical Study
Marketwire - Mon Mar 23
Friday, Mar 20, 2015
·SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Aradigm Corporation -- ARDM
PR Newswire - Fri Mar 20
Thursday, Mar 19, 2015
·Flamel Technologies Announces Fourth Quarter and Full Year Results of Fiscal Year 2014
Marketwire - Thu Mar 19
Wednesday, Mar 18, 2015
·Columbia Laboratories Reports Fourth Quarter and Full-Year 2014 Financial Results
PR Newswire - Wed Mar 18
Tuesday, Mar 17, 2015
·Obama crackdown fails to stop foreign mergers
at - Tue Mar 17
·Here are some Bay State firms working on drugs to treat Alzheimer's
at - Tue Mar 17
·Bio-Path reports 4Q loss
AP - Tue Mar 17
·Valeant Pharmaceuticals Prices Offering Of $1.45 Billion Of Common Shares
PR Newswire - Tue Mar 17
More Latest News...
Sponsor Results
Is He Cheating On You?
1) Enter His Email Address 2) See Hidden Pics & Social Profiles Now!
Business Services
Find Business Services Here!
Amos Sensoren
Sensors and Tansducers for measurements.
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Delivery Headlines
More Finance RSS Feeds

Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?